BODAPRA, created in 2011 (United States), from
126 sister brands
and 17479 competing brands.
The BODAPRA brand is owned by Celgene, a company listed in New York.
BODAPRA belongs to the Drug Manufacturers business sector.
Only companies with a strong brand or unique know-how benefit from this ability to set their prices without impacting demand and thus preserve their margins.